CAR T-Cell Therapy in Multiple Myeloma with Dr Jesús Berdeja
Dr Jesús Berdeja from the Sarah Cannon Research Institute in Nashville, Tennessee, discusses recent advances and future directions in the use of CAR T-cell therapy for the management of multiple myeloma. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayCARTMM21).
